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Abstract
Background Diversion colitis (DC) seems to be common in
stoma patients, and the restoration of the continuity of the
digestive tract is crucial for relief from the inflammatory pro-
cess. No prospective studies of the late effects of DC on the
lower gastrointestinal (GI) tract mucosa and the clinical con-
dition of patients have been reported.
Methods Data from 23 patients who underwent stoma creation
were analysed during the reversal period (A) and at an average
of 3 months (B1) and 5.6 years (B2) after restoration of GI tract
continuity. Every monitoring visit included endoscopy, histol-
ogy and assessment of the clinical condition of patients.
Results Shortly after GI tract restoration (B1), a significant
decrease in inflammation was observed. The Ki67 positivity
percentage increased, but this was not significant. At an aver-
age of 5.6 years after restoration (group B2), the clinical
symptoms were mild. More patients presented with endoscop-
ically detected inflammation of the mucosa, but its severity
was not significantly higher than that at 3 months after rever-
sal. Histological inflammation was more common, and its
severity was significantly higher than that shortly after rever-
sal but similar to that before reversal. The Ki67 positivity
percentage decreased at the last examination (B2).
Conclusions The results of this study show a complex recur-
rence of histological inflammation several years after GI tract
restoration but without clinical and endoscopic inflammation
and with good clinical condition. DC can potentially have a
late influence on the rectal mucosa, even after stoma closure.
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Introduction
Diversion colitis was described by Glotzer et al. in 1981 [1].
Twenty-five years ago, Harig et al. published the first report of
its treatment using short-chain fatty acids (SCFA) [2]. Despite
the inclusion of only four patients, the study has become a
classic regarding the treatment of this condition. Diversion
colitis (DC) is characterized by bleeding from an inflamed
large bowel mucosa that mimics idiopathic inflammatory
bowel disease and that may lead to stricture formation. For
many years, there were no criteria for the assessment of the
severity of DC, and very little was known about the long-term
effects of DC on the condition of the gastrointestinal (GI)
mucosa. Some papers report the occurrence of inflammation
and development of new clinical symptoms months after sto-
ma reversal [3, 4]. To date, there are 295 publications in
PubMed that include the key words ‘diversion colitis’, but in
most of these reports, DC is reported incidentally during anal-
ysis of other clinical conditions.
We therefore carried out a study to examine the long-term
consequences in the rectal mucosa of diversion colitis
resulting from proximal stoma formation for various patholo-
gies in a group of patients followed over 5 or more years after
closure of the stoma.
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Method
The prospective study included patients who had undergone
partial colonic resection with the simultaneous creation of a
temporary colostomy (Table 1).
In all cases, sigmoidostomy was created. Initially, there
were 52 eligible patients. The indications for primary surgery
included colorectal cancer (20 patients), diverticulitis (23 pa-
tients), volvulus of the sigmoid colon (1 patient), ovarian can-
cer (3 patients), traumatic bowel injury (5 patients) and iatro-
genic perforation (2 patients). The initial exclusion criteria
were the presence of inflammatory bowel disease such as
Crohn’s disease or ulcerative colitis and anastomotic leakage
after rectal cancer surgery.
The 52 patients were operated on at the Bielanski Hospital
between 2003 and 2008, and the continuity of their digestive
tract was restored. The patients were included in a follow-up
programme involving regular monitoring examinations by en-
doscopy, histology and clinical assessment. The long follow-
up resulted in drop-out of some of the patients because of
death due to other reasons, loss of contact with patient or lack
of acceptation the control investigation by the well-doing pa-
tients. The final analysed group consisted of 23 patients oper-
ated on for colorectal cancer (9 patients), diverticulitis (11
patients), bowel traumatic injury (2 patients) and iatrogenic
perforation (1 patient) (Fig. 1). The interval from the forma-
tion of the stoma to its closure was a median of 50.3 weeks.
Clinical investigation
Each patient was investigated on three occasions as follows:
2 weeks before colostomy closure (period A), 3 months (pe-
riod B1) after colostomy, and between 4 and 8 years (median
5.6 years) (period B2) after stoma closure. At every investiga-
tion, patients completed a questionnaire and underwent rigid
rectosigmoidoscopy and mucosal biopsy using flexible
colonoscopy. The basic demographic data of the patients were
also recorded. The questionnaire included questions about
clinical symptoms including mucous discharge, cramping ab-
dominal pain and tenesmus. Every symptom was scored as
0—absent, 1—mild or 2—severe. To compare the results of
the scoring, a control group was also created (group C). This
consisted of 15 patients undergoing endoscopy before
haemorrhoidectomy. No pathology other than haemorrhoids
was found in these patients by colonoscopy.
Endoscopic examination
One endoscopist performed the endoscopies for all patients.
Mechanical bowel preparation before endoscopy was omitted
to reduce bias. Random biopsies (three specimens) were per-
formed on the rectum approximately 7 cm above the dentate
line, even in patients with normal endoscopic findings. The
endoscopist was blinded to the patient’s symptoms. The en-
doscopic findings were expressed according to the scoring
system of Harig et al. [1] including erythema, oedema, friabil-
ity, granularity and erosions. Every finding was scored as
grade 0—absent, grade 1—mild or grade 2—severe.
Histopathological examination
The histopathological severity of colitis was assessed by two
independent histopathologists blinded to the patient’s clinical
data. The average score of the two investigations was used in
further analysis. The histopathological findings were scored as
acute inflammation (0 to 1), chronic inflammation (0 to 2),
eosinophilic infiltration (0 to 2), crypt architecture distortion
(0 to 1), follicular lymphoid hyperplasia (0 to 1) and crypt
abscess (0 to 1). The total score was validated and further
defined as mild (1 to 3), moderate (4 to 6) or severe (7 to 8) [3].
Table 1 Clinical characteristics of the study group
Clinical characteristics
Age 61.6 years (min. 47; max. 81)
Sex F 11
M 12
Primary diagnosis (reason for stoma creation) Colorectal cancer 9
Diverticulitis 11
Bowel traumatic injury 2
Iatrogenic perforation 1
Median time of diversion (days)
Specimen A
372 (min. 132; max. 982)
Median time between stoma reversal and first monitoring examination (days)
Specimen B1
88 (min. 78; max. 102)
Median time between stoma reversal and second monitoring examination (days)
Specimen B2
2038 (min. 1472; max. 2889)
Median length of the stump (cm) 19.5 (min. 8; max. 60)
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Immunohistological examination for Ki67
Themonoclonal antibodyKi67 (DakoCytomation,M7240) was
used to assess the cell turnover of the mucosa. In all specimens,
chromogen 3,3′-diaminobenzidine (DakoCytomation, K5007)
was used for antigen localization. Stained sections were
analysed field-by-field at a final magnification of 400×. Each
field was assigned a continuous score of positivity percentage,
representative of the approximate area of immunostaining. The
staining reaction obtained after the exclusion of the primary
antibody was used as a negative control.
Statistical analysis
Statistical analysis was performed using R statistical package
[5]. Spearman’s rank correlation was used for ordinal data
correlation analysis. Analysis of values between independent
groups that did not meet the criteria for normal distribution
defined by the Shapiro–Wilk test was performed using the
Wilcoxon matched-pairs test for paired and the Mann–
Whitney test for unpaired variables. The same tests were used
when comparing ordinal values in two independent groups.
When comparing two dependent groups, we used the
Wilcoxon signed-rank test. Comparison of ordinal values in
more than two dependent groups was performed using
Friedman’s test with a Wilcoxon–Mann–Whitney test as a
post hoc test. Wherever more than one analysis of the same
data was performed, we used the Bonferroni correction for the
p value.
Ethical considerations The study was performed with the
consent of the Ethics Committee of Centre for Postgraduate
Medical Education, Warsaw, Poland.
Fig. 1 A flowchart representing
the course of the study of DC
patients
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Results
Signs of DCwere observed by endoscopy, histology and clinical
score in the study group during the period of faecal diversion.
Twenty-two patients showed inflammation on endoscopy, all 23
patients had histopathological inflammation and 19 showed
clinical symptoms, valeted as a typical for DC (Table 2).
Three months after stoma closure, a significant decrease in
the severity of inflammation was observed for endoscopic,
histological and clinical scores (Table 3).
There was no statistically significant change in the Ki67
positivity. At a median 5.6 years after surgery, the incidence
and severity of endoscopically detected inflammation in-
creased, but no significant difference was found between the
first and second examinations after stoma reversal (B1 and
B2). The incidence of histological inflammation was high,
as seen in both previous examinations. The severity of
inflammation increased and was significantly higher than that
at B1. No significant differences were found between the se-
verity of histological inflammation in specimens taken during
diversion (A) and at B2. The Ki67 positivity percentage de-
creased not significantly from that at the previous examination
(B1). However, the positive trend was observed.
Changes in inflammation activity assessed by endoscopic,
histopathological and clinical scores and Ki67 positivity per-
centage are shown in Fig. 2.
Discussion
DC is still a problem and probably will remain so in the future
[6]. However, many patients need to maintain a colostomy for
long periods, and some will never attain the reconstruction of
intestinal continuity. As a consequence, it is expected that DC
Table 2 The incidence of endoscopic, histological and clinical inflammation of the mucosa in each study group
Signs of inflammation: Investigation A before
reversal (n = 23)
Investigation B1 3 months
after reversal (n = 23)
Investigation B2 5.6 years
after reversal (n = 23)
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Table 3 Severity of endoscopic, histological and clinical inflammation, and Ki67 reactivity before and after stoma reversal with level of significance
(Wilcoxon–Mann–Whitney test was used to determine p value) in study and control groups
A B1 B2 C p












A vs. B1 0.0002
A vs. B2 0.0006
A vs. C 0.0000
B1 vs. B2 0.2347
B2 vs. C 0.0001












A vs. B1 0.0024
A vs. B2 0.3868
A vs. C 0.0000
B1 vs. B2 0.0165












A vs. B1 0.0008
A vs. B2 0.0020
A vs. C 0.0008
B1 vs. B2 1.0000















A vs. B1 0.2327
A vs. B2 1.0000
A vs. C 0.0025
B1 vs. B2 0.0969
B2 vs. C 0.0000
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will impair the quality of life of a significant number of pa-
tients [7].
DC, especially as identified by endoscopic and histological
investigations, is very common in patients with stoma and can
occur in up to 100% of these patients [4], but there is usually
no significant correlation between the results of endoscopy
and histology and the clinical symptoms. In our study, we
found no correlation between the clinical symptoms and the
endoscopic and histological severity of DC. Other authors also
report no correlation between the endoscopic or histological
findings and symptoms such as mucous discharge, bleeding,
abdominal pain and tenesmus investigated before and after
stoma reversal [3].
There are different methods of treatment for DC, of which
the most effective seems to be SCFA, usually by means of
butyrate enemas [8, 9]. Promising results have also been re-
ported for autologous faecal transplantation [10]. Most au-
thors emphasize that althoughDC can be treated conservative-
ly, the best and most successful method of DC treatment is
surgery to reconstruct digestive tract continuity [9, 11]. Most
studies of DC are performed only up to stoma closure or for a
short time thereafter, and no serious clinical problems have
been reported. There is very limited follow-up information
about the period after reconstruction of digestive tract conti-
nuity. In one Korean study, the incidence of symptomatic DC
was reported as 63.3% after ileostomy creation, and 46.6% 5–
6 months after ileostomy closure; however, 30% of patients
developed diarrhoea as a new symptom [3]. Interesting data
were presented by Pacheco et al. [7]: during experimental
studies on the treatment of DC with either glutamine or buty-
rate, significant reductions in the density of collagen fibres in
tissue and in the rate of apoptosis within the epithelium were
observed, as well as a decrease in the levels of inflammatory
cytokines. These results may suggest that in non-treated DC,
both fibrosis and apoptosis may be increased.
Our observation of histological inflammation in patients
investigated several years after stoma closure is a surprising
result that is difficult to interpret unambiguously. However,
the results of the studies presented here suggest the possibility
that inflammatory lesions persist, or even in some cases, de-
velop further, as a continuation of the morphological and mo-
lecular changes in the colonic mucosa.
A completely opposite trend was observed in the analysis
of Ki67 positivity. Ki67 was used as cellular marker for pro-
liferation, also commonly coexisting in premalignant and ma-
lignant conditions.
The low level observed during diversion increased shortly
after digestive tract restoration, but after several years, the
level decreased to one similar to that observed during diver-
sion. These observed changes were not statistically signifi-
cant, probably because of the high value of the standard devi-
ation and the small numbers of patients investigated. A low
level of Ki67 positivity may be correlated with low prolifera-
tion. This is supported by the observation that prolonged di-
version causes involution and atrophy of the relevant segment.
The clinical effect of this situation can be a poor functional
outcome [12]. The low level of Ki67 positivity in DC also
correlates with a low possibility of malignancy. It is also pos-
sible, comparing individuals with ulcerative colitis and those
with DC, that the different tissue expression patterns exhibited
by mucins may be related to a lower possibility of neoplastic
transformation in gut segments that are excluded from the
faecal stream because of diseases other than inflammatory
intestinal diseases [13]. After stoma closure, Ki67 positivity
increased (1.05 to 4.28% reactivity), while in the long-term
follow-up, we observed decreasing Ki67 positivity, compared
to patients with colostomy before stoma reversal (group A)
and shortly after stoma closure (group B1). From the other
point, it is necessary to remember that in all patients after
stoma formation and reversal (A, B1, B2), positivity of Ki67
was higher than that in control group (C). It can be explained
as a result of diversion colitis, stimulating the mucosal cells to
proliferation; also, long time after stoma reversal, there is lack
of evidences to clearly explain this fact.
The decreased level of Ki67 correlated with greater sever-
ity of morphological inflammation. Only a non-significant
increase in the endoscopic signs of inflammation and no in-
crease in the severity of clinical symptoms were observed.
The observations presented here demonstrate the long-term
consequences of DC. After stoma reversal, all manifestations
of colitis decreased significantly, but after several years, in-
flammation was observed at a morphological level. There are
no data in the literature to compare with this observation, and
therefore, further long-term study of DC patients is necessary.
Fig. 2 Changes in inflammation activity assessed by endoscopic,
histological and clinical scores, and Ki67 positivity percentage. The
statistically significant differences between analysed parameter in group
A and other groups are marked with black star (details are in Table 3)
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Of course, small number of patients analysed in our paper is a
strong limitation of the study, and the presented results and
conclusions should be interpreted with caution.
It is difficult to identify the factors potentially influencing
the risk of histological inflammation several years after stoma
closure. There is controversy regarding histopathological
analyses of colon mucosal segments that have been excluded
from the faecal stream, which demonstrates that the disease
follows a variable course and that there is no characteristic
pattern of changes [14–16].
A unique feature of this study is the long observation time,
which sheds a slightly different light on the assessment of the
natural course of DC and its consequences in the long term
after the restoration of GI tract continuity. The histological
inflammation of the colonic mucosa observed many years
after stoma closure in our study warrants further investigation
of this phenomenon.
Open Access This article is distributed under the terms of the
Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted
use, distribution, and reproduction in any medium, provided you give
appropriate credit to the original author(s) and the source, provide a link
to the Creative Commons license, and indicate if changes were made.
References
1. Glotzer DJ, Glick ME, Goldman H (1981) Proctitis and colitis
following diversion of the fecal stream. Gastroenterology 80:438–
441
2. Harig JM, Soergel KH, Komorowski RA, Wood CM (1989 Jan 5)
Treatment of diversion colitis with short-chain-fatty acid irrigation.
N Engl J Med 320(1):23–28
3. Son DN, Choi DJ, Woo SU, Kim J, Keom BR, Kim CH, Baek SJ,
Kim SH (2013) Relationship between diversion colitis and quality
of life in rectal cancer. World J Gastroenterol 19(4):542–549
4. Baek SJ, Kim SH, Lee CK, Roh KH, Keum B, Kim CH, Kim J
(2014) Relationship between the severity of diversion colitis and
the composition of colonic bacteria: a prospective study. Gut Liver
8(2):170–176
5. R Core Team (2014). R: a language and environment for statistical
computing. R Foundation for Statistical Computing, Vienna,
Austria. URL http://www.R-project.org/.
6. Szczepkowski M, Banasiewicz T, Krokowicz P, Dziki A, Wallner
G, Drews M, Herman R, Lorenc Z, Richter P, Bielecki K,
Tarnowski W, Kruszewski J, Kładny J, Głuszek S, Zegarski W,
Kielan W, Paśnik K, Jackowski M, Wyleżoł M, Stojcev Z,
Przywózka A (2014) Polish consensus statement on the protective
stoma. Pol Przegl Chir 86(8):391–404
7. Pacheco RG, Esposito CC, Müller LC, Castelo-Branco MT,
Quintella LP, Chagas VL, de Souza HS, Schanaider A (2012) Use
of butyrate or glutamine in enema solution reduces inflammation
and fibrosis in experimental diversion colitis.World J Gastroenterol
18(32):4278–4287
8. Tortora F, Purchiaroni E, Scarpellini V, Ojetti M, Gabrielli G, Vitale
G, Giovanni A (2012) Gasbarrini: colitides. Eur Rev Med
Pharmacol Sci 16(13):1795–1805
9. Szczepkowski M, Kobus A, Borycka K (2008) How to treat diver-
sion colitis?: current state of medical knowledge, own research and
experience. Acta Chir Iugosl 55(3):77–81
10. Gundling F, Tiller M, Agha A, Schepp W, Iesalnieks I (2015 Jan)
Successful autologous fecal transplantation for chronic diversion
colitis. Tech Coloproctol 19(1):51–52
11. Szczepkowski M.: Clinical pathology of diversion colitis. Centre
for Postgraduate Medical Education,Warsaw, 2002.
12. Koutroubakis IE (2008) Spectrum of non-inflammatory bowel dis-
ease and non-infectious colitis.World J Gastroenterol 14(48):7277–
7279
13. Martinez CAR, Nonose R, Spadari APP, Máximo FR, Priolli DG,
Pereira JA, Margarido NF (2010) Quantification by computerized
morphometry of tissue levels of sulfomucins and sialomucins in
diversion colitis in rats. Acta Cir Bras 25(3):231–240
14. Kiely EM, Ajayi NA, Wheele RA, Malone M (2001) Diversion
procto-colitis: response to treatment with short-chain fatty acids. J
Pediatr Surg 36:1514–1517
15. Giardiello FM, Lazenby AJ, Bayless TM (1995) The new colitides:
collagenous, lymphocytic, and diversion colitis. Gastroenterol Clin
N Am 24:717–729
16. Biondo-Simões MLP, Greca FH, Ioshi S, Abicalaffe MD, Colnaghi
MC, Mattos e Silva E, Yamasaki ES, Smaniotto G (2000) Colite do
cólon excluso: modelo experimental em ratos. Acta Cir Bras
15(Suppl. 3):7–11
Int J Colorectal Dis
